← Back to headlines
Eli Lilly Price Target Raised After FDA Approval for Fundayo
Eli Lilly and Company (LLY) saw its price target raised by analysts following the FDA's approval of its new drug, Fundayo.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Global Oil Prices Remain High Amid Persistent Middle East Tensions
just now
Two Suspects Charged in Quezon City Diesel Pilferage Incident
just now
Philippines to Begin Service Contracting for Public Utility Vehicles
just now
Philippine Anti-Money Laundering Council Investigates P802M Flow into Zaldy Co's Accounts
just now